Plantar Pressures After Pressure Release of the Flexor Digitorum Brevis Muscle Versus a Non-emission Laser.

August 3, 2024 updated by: EVA MARIA MARTÍNEZ JIMENEZ, Mayuben Private Clinic

Plantar Pressures After Pressure Release of the Flexor Digitorum Brevis Muscle Versus a Non-emission Laser: Clinical Trial.

In this study we will test the effects of pressure release on the Flexor digitorum brevis muscle on the plantar pressures variables using a pressure platform.

Study Overview

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • San Sebastián De Los Reyes, Madrid, Spain, 28702
        • Mayuben Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria:

  • Participants who came to the clinic presenting with pain in both heels and who were diagnosed with active or latent myofascial trigger point in bilateral flexor digitorum brevis muscles.
  • Myofascila trigger points of flexor digitorum brevis were the only ones diagnosed in the foot.
  • All participants with normal body mass, without obesity.

Exclusion criteria:

  • Diagnosis of lower limb injury, such as plantar fasciitis, tendinopathy, bursitis, ligamentous injuries.
  • History of previous lower limb surgery.
  • Participants will not be subjected to ankle stretching or any other treatment.
  • Diabetes due to possible elevation of plantar pressure.
  • Toe deformities such as hammertoes and hallux valgus due to possible alteration of plantar pressure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pressure release
Application of pressure release as a trigger point treatment of the flexor digitorum brevis muscle. Performing 3 pressure cycles until the disappearance of the referred pain for a minimum of 90 seconds.
Release of pre-pressure at the latent trigger point of flexor digitorum brevis
Sham Comparator: Non-emision Laser
Application of a non-emitting laser for 5 minutes.
Non emision laser in Flexor digitorum brevis latent trigger point

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Variables of plantar pressures with platform before non-emission laser
Time Frame: Through study completion, an average of 2 days
For 30 seconds we will record the plantar pressure variables in grams per square centimetre.
Through study completion, an average of 2 days
Variables of plantar pressures with platform before pressure release
Time Frame: Through study completion, an average of 2 days
For 30 seconds we will record the plantar pressure variables in grams per square centimetre.
Through study completion, an average of 2 days
Variable footprint planting surface with platform before non-emission laser
Time Frame: Through study completion, an average of 2 days
For 30 seconds we will record the area of the footprint in square centimetres.
Through study completion, an average of 2 days
Variable footprint plantar surface with platform before pressure release
Time Frame: Through study completion, an average of 2 days
For 30 seconds we will record the plantar pressure variables in grams per square centimetre.
Through study completion, an average of 2 days
Variables of plantar pressures with platform after non-emission laser
Time Frame: Through study completion, an average of 2 days
For 30 seconds we will record the plantar pressure variables in grams per square centimetre.
Through study completion, an average of 2 days
Variables of plantar pressures with platform after preassure release
Time Frame: Through study completion, an average of 2 days
For 30 seconds we will record the plantar pressure variables in grams per square centimetre.
Through study completion, an average of 2 days
Variable footprint planting surface with platform after non-emission laser
Time Frame: Through study completion, an average of 2 days
For 30 seconds we will record the area of the footprint in square centimetres.
Through study completion, an average of 2 days
Variable footprint planting surface with platform after pressure release
Time Frame: Through study completion, an average of 2 days
For 30 seconds we will record the area of the footprint in square centimetres.
Through study completion, an average of 2 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eva María Martínez-Jiménez, PhD, Universidad Complutense de Madrid

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 24, 2024

Primary Completion (Actual)

July 28, 2024

Study Completion (Actual)

August 3, 2024

Study Registration Dates

First Submitted

July 7, 2024

First Submitted That Met QC Criteria

July 11, 2024

First Posted (Actual)

July 12, 2024

Study Record Updates

Last Update Posted (Actual)

August 6, 2024

Last Update Submitted That Met QC Criteria

August 3, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myofascial Pain Syndrome

Clinical Trials on Pressure release

Subscribe